Why is Lotus International an expert in supplying mass medicines worldwide?
For a long time India has been quietly supplying generic drugs worldwide despite China’s dominance. With the advent of COVID-19, its pharma sector gains more recognition. As suppliers of mass medicines many companies enjoy good business in the world market. The pressure for specific drugs overseas is accelerating.
Lotus International has been in supplying mass medicine overseas since 1991. The company continues to meet delivery challenges to its clients based in several countries. Currently, they send crucial Covid medicines from India. What makes them perform successfully under pressure.
Key elements for mass supply of drugs
Cracking challenges and opportunities
Today, India has very dedicated zones for pharma companies to operate their business. The country is offering incentives to help companies to do better with digital innovations and improvement in technology. As the health sector is important, companies like Lotus International have kept pace with several global trends and demands. It is one of the few companies to redefine the meaning of wholesale pharmacy in India with its ethical way of working for overseas clients.
Importance of cold chain medical supply chain
Lotus International uses the best cold chain supply to ensure the drugs reach a destination at the most optimal temperatures for usage of the patients. The company is committed to ethical methodologies for clients receive the consignment on time and at required temperatures. There is a critical need to keep focus more on temperature control rather than being cost-effective. Distribution in certain geographies require stringent network. Lotus International follows all protocols and compliances as its business is spread over CIS, Africa, Latin America, SE Asia and GCC nations.
In terms of volume India is the 3rd largest supply of mass medicines in the world.
Less loss of business due to temperature variations
The pandemic has created a need for organized logistics related to sending medicines abroad. With distribution of current supplies of Covid medicines from India, once again pharma companies are realigning their strategies to manufacture and send APIs. With better facilities and help from the government, good quality mass production is a reality. Good warehousing facilities, temperatures are controlled at all stages until drugs reach their destination. Vishakapatnam and Mumbai are good business hubs for pharmaceuticals in India. This is yet another factor assisting the country to be a center for medical research and development.
Lotus international continues to create workable solutions for mass supply of formulations for its clients. It has successfully partnered with the right people to send COVID-19 vaccines to various countries. The delicate vaccine distribution remains a solid template to improve its offerings of other generic drugs for world consumption.
We are ready to take on new global clients and serve them with high performing mass medicines. Do let us know how we can help your specific requirements.